TY - JOUR T1 - Positive allosteric modulators of metabotropic glutamate receptor 5 as tool compounds to study signaling bias JF - Molecular Pharmacology JO - Mol Pharmacol DO - 10.1124/molpharm.120.000185 SP - MOLPHARM-AR-2020-000185 AU - Angela Arsova AU - Thor C. Møller AU - Shane D. Hellyer AU - Line Vedel AU - Simon R. Foster AU - Jakob L. Hansen AU - Hans Bräuner-Osborne AU - Karen J. Gregory Y1 - 2021/01/01 UR - http://molpharm.aspetjournals.org/content/early/2021/02/18/molpharm.120.000185.abstract N2 - Positive allosteric modulation of metabotropic glutamate type 5 (mGlu5) receptor has emerged as a potential new therapeutic strategy for the treatment of schizophrenia and cognitive impairments. However, positive allosteric modulator (PAM) agonist activity has been associated with adverse side effects, and neurotoxicity has also been observed for pure PAMs. The structural and pharmacological basis of therapeutic vs adverse mGlu5 PAM in vivo effects remains unknown. Thus, gaining insights into the signaling fingerprints, as well as the binding kinetics of structurally diverse mGlu5 PAMs, may help in the rational design of compounds with desired properties. We assessed the binding and signaling profiles of N-methyl-5-(phenylethynyl)pyrimidin-2-amine (MPPA), 3-cyano-N-(2,5-diphenylpyrazol-3-yl)benzamide (CDPPB), and 1-[4-(4-chloro-2-fluoro-phenyl)piperazin-1-yl]-2-(4-pyridylmethoxy)ethenone (compound 2c, a close analogue of 1-(4-(2-chloro-4-fluorophenyl)piperazin-1-yl)-2-(pyridin-4-ylmethoxy)ethanone (CPPZ)) in human embryonic kidney 293A (HEK293A) cells stably expressing mGlu5 using Ca2+ mobilization, inositol monophosphate (IP1) accumulation, extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation, and receptor internalization assays. Of the three allosteric ligands, only CDPPB had intrinsic agonist efficacy and also had the longest receptor residence time and highest affinity. MPPA was a biased PAM, showing higher positive cooperativity with orthosteric agonists in ERK1/2 phosphorylation and Ca2+ mobilization over IP1 accumulation and receptor internalization. In primary cortical neurons, all three PAMs showed stronger positive cooperativity with DHPG in Ca2+ mobilization over IP1 accumulation. Our characterization of three structurally diverse mGlu5 PAMs provides further molecular pharmacological insights and presents the first assessment of PAM-mediated mGlu5 internalization. Significance Statement Enhancing metabotropic glutamate receptor subtype 5 (mGlu5) activity is a promising strategy to treat cognitive and positive symptoms in schizophrenia. It is increasingly evident that positive allosteric modulators (PAMs) of mGlu5 are not all equal in preclinical models; there remains a need to better understand the molecular pharmacological properties of mGlu5 PAMs. Here, we report detailed characterization of the binding and functional pharmacological properties of mGlu5 PAMs, including the first study of the effects of mGlu5 PAMs on receptor internalization. ER -